These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23999841)

  • 1. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67.
    Li D; Han Z; Liu J; Zhang X; Ren J; Yan L; Liu H; Xu Z
    Med Oncol; 2013 Dec; 30(4):702. PubMed ID: 23999841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of HDGF and its implication in stage I non-small cell lung cancer].
    Zhou SJ; Xu SF; Zhang HQ; Liu ZD
    Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):927-30. PubMed ID: 18478933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome.
    Li SZ; Zhao YB; Cao WD; Qu Y; Luo P; Zhen HN; Chen XY; Yan ZF; Fei Z
    Med Oncol; 2013; 30(3):622. PubMed ID: 23771798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TERT promoter mutations in penile squamous cell carcinoma: high frequency in non-HPV-related type and association with favorable clinicopathologic features.
    Kim SK; Kim JH; Han JH; Cho NH; Kim SJ; Kim SI; Choo SH; Kim JS; Park B; Kwon JE
    J Cancer Res Clin Oncol; 2021 Apr; 147(4):1125-1135. PubMed ID: 33635430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.
    Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K
    Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients.
    Zhou QH; Han H; Lu JB; Liu TY; Huang KB; Deng CZ; Li ZS; Chen JP; Yao K; Qin ZK; Liu ZW; Li YH; Guo SJ; Ye YL; Zhou FJ; Liu RY
    Cancer Commun (Lond); 2020 Jan; 40(1):3-15. PubMed ID: 32125093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.
    Lin YW; Huang ST; Wu JC; Chu TH; Huang SC; Lee CC; Tai MH
    BMC Cancer; 2019 Nov; 19(1):1083. PubMed ID: 31711427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.
    Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH
    Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of Ki-67 expression in penile squamous cell carcinoma.
    Stankiewicz E; Ng M; Cuzick J; Mesher D; Watkin N; Lam W; Corbishley C; Berney DM
    J Clin Pathol; 2012 Jun; 65(6):534-7. PubMed ID: 22447920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma.
    Hu X; Chen M; Liu W; Li Y; Fu J
    Urol Oncol; 2019 Jul; 37(7):452-461. PubMed ID: 31053522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.
    Vosmik M; Laco J; Sirak I; Beranek M; Hovorkova E; Vosmikova H; Drastikova M; Hodek M; Zoul Z; Odrazka K; Petera J
    Pathol Oncol Res; 2014 Jan; 20(1):131-7. PubMed ID: 23913252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.
    Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W
    World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoma-derived growth factor upregulation is correlated with prognostic factors of early-stage cervical adenocarcinoma.
    Tsai CC; Huang SC; Tai MH; Chien CC; Huang CC; Hsu YC
    Int J Mol Sci; 2014 Nov; 15(11):21492-504. PubMed ID: 25421244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma.
    Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S
    Dis Markers; 2014; 2014():298795. PubMed ID: 24692842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M
    Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.
    Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L
    J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M
    Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.
    Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X
    Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.
    Park S; Nam SJ; Keam B; Kim TM; Jeon YK; Lee SH; Hah JH; Kwon TK; Kim DW; Sung MW; Heo DS; Bang YJ
    Cancer Res Treat; 2016 Apr; 48(2):518-26. PubMed ID: 26194375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.